Gupta R C, Nair C R, Jindal S K, Malik S K
Int J Clin Pharmacol Ther Toxicol. 1984 May;22(5):259-64.
Isoniazid acetylation phenotypes were determined in 110 cases (55 of pulmonary tuberculosis and 55 of nontubercular chest diseases) by sulphadimidine acetylation test (Bratton and Marshall method). Cases with more than 65% of acetylated sulphadimidine in urine at 6th h were classified as fast acetylators, those with less than 50% as slow acetylators and others with values between 50-65% as intermediate acetylators. There were 39.09% fast, 46.36% intermediate and 14.55% slow acetylators. Possible factors for difference in results from other Indian studies have been discussed. Sulphadimidine acetylation showed no variation due to presence of disease, age, sex, religion, place of origin, height, weight and smoking habits. However, 79% of those who took alcohol regularly turned out to be fast acetylators.
采用磺胺二甲嘧啶乙酰化试验(布拉顿和马歇尔法)对110例患者(55例肺结核患者和55例非结核性胸部疾病患者)的异烟肼乙酰化表型进行了测定。在第6小时时,尿中乙酰化磺胺二甲嘧啶含量超过65%的患者被归类为快速乙酰化者,低于50%的为慢速乙酰化者,50%-65%之间的为中间型乙酰化者。快速乙酰化者占39.09%,中间型乙酰化者占46.36%,慢速乙酰化者占14.55%。文中讨论了与其他印度研究结果存在差异的可能因素。磺胺二甲嘧啶乙酰化情况未因疾病、年龄、性别、宗教、出生地、身高、体重和吸烟习惯而出现变化。然而,经常饮酒的患者中有79%为快速乙酰化者。